event tracking

International Linked Clinical Trials (iLCT)

25 results.

January 10, 2023 Cough medicine offers hope of new treatment to slow the progression of Parkinson’s disease

London, United Kingdom (Jan. 10, 2023) — Following promising results reported at Phase 2 in 2020, a large-scale Phase 3 clinical trial of ambroxol,…

April 5, 2022 Top-line results reported from clinical trial of diabetes drug in Parkinson’s

This release has been republished from Cure Parkinson’s. Researchers from Cedars Sinai Hospital, Los Angeles, have presented their initial top line results of

December 13, 2021 A year — and a quarter century — in review

As 2021 comes to a close, so too does Van Andel Institute’s celebration of our 25th anniversary. The Institute’s story began with a vision: to…

March 18, 2021 New uses for existing medications provide hope for Parkinson’s disease breakthroughs

Drug repurposing program seeks to find treatments that slow or stop Parkinson’s progression and serve as a roadmap for similar initiatives in other diseases Could…

September 20, 2020 International Linked Clinical Trials strategic funding for Parkinson's now worth US$6.75 million

LONDON (Sept. 21, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute (VAI) are delighted to welcome a third strategic funding partner, The…

February 12, 2020 $4.5 million co-funding agreement for Parkinson’s research announced

NOTE: This release was originally published by The Cure Parkinson’s Trust LONDON (Feb. 13, 2020) — The Cure Parkinson’s Trust (CPT) and Van Andel Institute…

October 17, 2019 How Van Andel Institute supports clinical trials through collaboration and connection

Institute serves as a connector that fosters discovery of potential new treatments Clinical trials can be a bastion of hope for people living with terminal…